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Abstract
Background: Despite recommendations for monitoring patients with chronic and high-risk conditions, gaps still
remain. These gaps are exacerbated in outpatient care, where patients and clinicians face challenges related to care
coordination, multiple electronic health records, and extensive follow-up. In addition, low-income and racial/ethnic
minority populations that are disproportionately cared for in safety net settings are particularly at risk to lapses in
monitoring.
Methods: We aim to implement and evaluate a health information technology platform developed using systems
engineering methodologies. The implementation is situated in a clinic that monitors patients with head and neck
cancer within a large, urban, publicly funded hospital. Our study will evaluate the time it takes for patients to
progress through key treatment milestones prior to and after implementation of the tool. We will use models
controlling for secular trend to estimate the effect of the tool on improving timely and successful completion of
guideline-based care processes.
Discussion: This protocol details the evaluation of the effectiveness of a human-centered health information
technology intervention on improving timely delivery of care for high-risk populations. Other settings, including
those that face challenges related to limited resources to devote to safety programs and fragmented health
information technology, may benefit from this approach.
Trial registration: ClinicalTrials.gov, NCT03546322. “Customized Registry Tool for Tracking Adherence to Clinical
Guidelines for Head and Neck Cancers.” Registered 1 June 2018.
Keywords: Patient monitoring, Patient safety, Ambulatory care, Organizational interventions, Systems engineering
Background
Since the publication of “To Err is Human” and other
subsequent reports by the Institute of Medicine, there
has been increasing focus on harms caused by med-
ical care [1–3]. Errors of omission, or failing to de-
liver needed treatment, are especially common in the
ambulatory setting, where patients receive only 55%
of recommended preventive care. Those with chronic
conditions fare no better, receiving only 56% of rec-
ommended care [4].
Delivery of appropriate care in the ambulatory setting fre-
quently requires monitoring and treatment over multiple
visits and often extended periods of time, particularly for
those with chronic diseases or complex conditions. Missed
monitoring may put patients at high-risk of adverse effects
of treatment or failed detection of progression of disease. In
addition to periodic monitoring, patients with complex
conditions may require coordination between multiple spe-
cialties and complex treatment regimens that require timely
completion of needed steps. For example, patients with
cancer often require extensive diagnostic workup, evalu-
ation by an interdisciplinary group of providers, and coord-
ination of multiple treatment modalities. In head and neck
cancer, the National Comprehensive Cancer Network
(NCCN) has published guidelines for recommended pre-
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treatment workup, treatment, and post-treatment
monitoring [5]. Despite the presence of these guide-
lines, fewer than half of patients undergoing surgery
for head and neck squamous cell carcinoma receive
post-surgery radiation within the timeframe recom-
mended by NCCN guidelines [6]. Unsurprisingly,
studies show an association between delays in treat-
ment initiation and increased mortality [7]. Treat-
ment interruptions have also been associated with
both persistent disease [8] and mortality [9]. Perhaps
more concerning, the proportion of patients receiv-
ing guideline-based care has decreased over time,
and patients with lower socioeconomic status who
receive care regardless of insurance status or their
ability to pay in safety net settings appear to be
most vulnerable [6, 10]. Though reasons for failure
to adhere to guidelines are complex, lapses are fre-
quently the result of the inability of clinics and
health systems to proactively identify patients who
meet criteria for guideline-based diagnostic or thera-
peutic interventions [11].
Traditionally, face-to-face visits have been the primary
means of monitoring patients and ensuring completion
of treatment steps. However, given the frequency of er-
rors of omission—missed cancer diagnoses constitute
the leading cause of paid medical malpractice claims
among outpatients—solutions to systematically identify
upcoming and overdue monitoring across a population
of patients are needed [12, 13]. Similar to cancer screen-
ing, which is now often based on electronic registries
and outreach to patients rather than purely visit-based
activity, there is an opportunity to use technology and
team-based workflows to enhance outpatient monitoring
for high-risk conditions.
As part of the process for developing the information
technology (IT) tool used in this study, we conducted a
series of qualitative interviews with practitioners in a
number of clinics involved in delivering care to patients
with chronic or complex medical conditions at high-risk
of experiencing monitoring related medical errors. We
applied a technique known as journey mapping to map
the process of patient monitoring in each clinic and
identify difficult or high-risk steps in the monitoring
process [14]. Focusing on “pain points” identified
through the journey mapping process for the Otolaryn-
gology Clinic at the Zuckerberg San Francisco General
Hospital, we applied a framework adapted from Systems
Engineering Initiative for Patient Safety (SEIPS) [15] to-
ward the development of a health IT tool that allows for
context-specific customization of monitoring and treat-
ment protocols for patients with head and neck cancer.
This tool enables the clinic to develop custom diagnostic
and treatment plans for patients with head and neck
cancer, and facilitates subsequent population level
tracking of completion of needed diagnostic or treat-
ment steps.
We aim to implement the tool developed through this
journey mapping process in the head and neck cancer
clinic within a large safety net hospital and evaluate im-
pact of this tool on timeliness of diagnostic evaluation,
treatment initiation, and monitoring, as well as adher-
ence to established protocols. Our objective here is to
describe the study protocol for this pilot evaluation.
Methods
Study design
This study will evaluate implementation of a health IT
tool designed to track patient progress toward diagnostic
evaluation, treatment, and post-treatment monitoring
for head and neck cancer. The study will evaluate the
amount of time it takes patients to progress through key
treatment milestones prior to and after implementation
of the tool. The study design is a cohort study consisting
of two cohorts of patients—a pre-treatment cohort in-
cluding patients who have received a diagnosis of head
and neck cancer but have not started treatment, and a
post-treatment cohort of patients who have initiated
treatment. Models controlling for secular trend will be
used for data analysis to estimate the effect of tool im-
plementation on improving timely and successful com-
pletion of guideline-based care processes. This analytic
approach will help separate out the effect of the inter-
vention from other temporal trends in care process com-
pletion. This study was approved by the University of
California, San Francisco Institutional Review Board (12-
09658) and is registered on ClinicalTrials.gov (Protocol
ID: P30HS023558-1).
Clinical setting
This study will take place within the Otolaryngology-
Head and Neck Surgery Clinic at the Zuckerberg San
Francisco General Hospital, a large county hospital affili-
ated with a tertiary care academic center. Patients served
by this clinic are publicly insured. While the clinic has
used an electronic health record for 22 years, it faces
challenges, shared by many safety net systems, associated
with coordinating care across multiple electronic plat-
forms and record-keeping systems. Until adoption of this
tool, the clinic did not have access to an integrated elec-
tronic registry system to monitor progress of care plans
for patients undergoing diagnostic workup or treatment
for head and neck cancers.
Health IT tool
The intervention evaluated in this study is an innovative
workflow that incorporates an electronic registry tool.
The tool integrates data from several, fragmented elec-
tronic medical records and allows clinic staff to monitor
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patient progress through care plans across the clinic’s
entire panel (Fig. 1). Prior to development of this tool,
the clinic relied on tracking methods requiring intensive
manual data entry to populate a database that was not
integrated with the medical record. These methods in-
cluded a system of paper note cards and later an elec-
tronic spreadsheet to track patient progress. Using this
tool requires changes in the clinic team’s workflow and
communication.
The tool evaluated here was developed to address key
process challenges identified through a “journey map-
ping” method with clinic staff in five clinics that monitor
high-risk cancer situations: otolaryngology, pulmonary,
breast, urology, and gastroenterology [14]. The journey
mapping process identified two vulnerabilities present
across all five sub-specialty clinics studied, namely (1)
the need to track patient progress toward diagnostic or
therapeutic goals and (2) the difficulty in creating com-
prehensive patient lists for monitoring. Practitioners in
the Otolaryngology-Head and Neck Surgery Clinic also
identified challenges related to coordinating multi-
specialty treatment plans. Our team mapped processes
identified during the journey mapping exercise onto the
SEIPS model for work system, a model that describes
the interrelated components of people, tasks, technol-
ogy/tools, organization, and environment that make up
clinical work systems [15]. We chose to focus on devel-
oping a solution to address challenges in work systems
related to tasks and technology, as these were both the
most clear areas of challenge and the most immediately
amenable to change in the Otolaryngology-Head and
Neck Surgery Clinic. In collaboration with CipherHealth,
a health IT company, we developed a registry tool that
integrates clinical data from multiple electronic health
records. This tool allows for creation of clinic-specific
treatment plans (Fig. 2) and tailored queries to identify
patients who are overdue for completing key steps of
their assigned treatment plan (Fig. 3).
Chart review
Chart review will be conducted for all patients in the
Otolaryngology-Head and Neck Surgery Clinic undergo-
ing diagnostic workup, treatment, or post-treatment
monitoring for head and neck cancer for the 2-year
period leading up to implementation of the tool and the
2-year period after the tool has been implemented (with
the 6 months prior to tool implementation excluded to
avoid misclassification of exposure to the intervention,
as discussed below). All patients with confirmed diagno-
sis of head and neck cancer who were seen in the clinic
at least once will be included in the chart review. Based
on prior clinic chart review, there are about 75 patients
with head and neck cancer seen in the clinic each year
who meet enrollment criteria. Thus, the chosen 4-year
time period was selected to allow for inclusion of ap-
proximately 300 patients in our sample. Data will be ex-
tracted from patient charts and will include patient
demographic factors, details of the diagnosis, and key
treatment dates (Table 1). Unless noted, all clinical data
will be collected from the medical record for both the
intervention and control time periods, to minimize dif-
ferential data collection methods that may influence
comparisons.
Outcomes
Patients included in the study will be divided into two
separate cohorts. The pre-treatment cohort will include
patients with a confirmed diagnosis of head and neck
Fig. 1 The health IT tool integrates data from three separate HL7 data sources representing registration, lab, and radiology data into a
single database
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cancer but who have not yet initiated treatment. The
post-treatment cohort will include patients who have
initiated treatment and are undergoing additional treat-
ment modalities and monitoring. Patients who received
a diagnosis of head and neck cancer and initiated any
treatment will thus be present in both cohorts. Out-
comes for each cohort consist of completion of key steps
in the evaluation and treatment process, and are sum-
marized in Table 2. Usual clinic protocols will be
employed to address patients who are lost to follow-up
(three outreach attempts, then moved to lost to follow-
up list). Patients who are lost to follow-up will be
included in the final analysis and will be considered to
have not met the process outcome for their given cohort
(i.e., it will be assumed that patients lost to follow-up
from the pre-treatment cohort never initiated
treatment).
Classification of exposure to the intervention
Patients will be considered unexposed to the interven-
tion if they entered one of the cohorts at least six
months prior to implementation of the health IT tool
intervention. Patients who entered a cohort less than 6
months prior to implementation of the intervention will
Fig. 2 A screenshot depicting one of the clinic-specific treatment plans co-designed with the Otolaryngology-Head and Neck Surgery Clinic. After
assigning a patient to this plan, care providers will be automatically prompted to complete its associated tasks, such as ordering post-treatment
imaging for a patient two months after enrollment
Fig. 3 A screenshot of the health IT tool’s panel management functionality. Users can run queries to prioritize patients overdue for key steps of
their assigned monitoring plan. Patient names are fictitious for demonstration purposes
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be excluded from that cohort. All patients entering a co-
hort after implementation of the tool will be considered
exposed to the intervention for that cohort. For example,
if a patient was diagnosed with head and neck cancer 3
months prior to implementation of the intervention and
initiated treatment 1 week after implementation of the
intervention, they would be excluded from the pre-
treatment cohort and would be included in the post-
treatment cohort and considered exposed to the
intervention.
Implementation outcomes
The key implementation outcome is feasibility. We will
also measure several components of tool utilization to
better understand the actor, dose, temporality, and ac-
tion target of the intervention [16]. Data collection on
these parameters will occur through a quarterly survey
of clinic staff using the tool and through five randomly
selected clinic days when the investigators will observe
clinic staff and any use of the tool that occurs. The sur-
vey will ask staff to report their role in the clinic and
recall for the prior week the amount of time that the
tool was used, timing of use, and number of patients
outreached through the use of the tool. The feasibility
objective for this pilot study is to achieve consistent use
throughout all clinic sessions reaching all eligible
patients. The feasibility outcome which will determine
success and trigger proceeding to the main trial is
achievement of significant use: use during at least 80%
of clinic sessions and for 80% of eligible patients.
Analysis
Incorporation of a term for calendar time into our models
for primary and secondary outcomes will allow us to con-
trol for secular trend. This strengthens the analysis by
eliminating temporal improvements in clinical care pro-
cesses that are unrelated to the intervention. Time to
event analyses will use Cox proportional hazards models.
For binary outcomes including loss to follow-up and com-
pletion of treatment steps such as post-treatment radi-
ation within 6 weeks, logistic regression will be used.
Table 1 Data elements collected in chart review
Phase/data type Data element
General: demographics Gender
Race/ethnicity
Primary language
Insurance status
General: social
characteristics
Smoking status
History of alcohol use
History of other substance abuse
History of homelessness/being marginally
housed
Comorbidities
History of HIV/AIDS
General: utilization Otolaryngology-Head and Neck Surgery visit
dates and status (attended/canceled/no-show/
scheduled)
Medical oncology visit dates and status
(attended/canceled/no-show/scheduled)
Radiation oncology visit dates and status
(attended/canceled/no-show/scheduled)
Patient only seen for hospitalization
Most recent visit date
General: outcomes Overall follow-up time
Survival
General: results Imaging for cancer monitoring
All imaging
Thyroid-stimulating hormone test dates and
results
All lab test dates and results
Pathology dates and results
1. Workup and
treatment planning
Date of diagnosis
Date of referral to tumor board
Date of presentation at tumor board
Date imaging appointments sent, scheduled,
and completed
Date referrals sent, scheduled, and completed
TNM staging
Site
Histology
P16 test results*
Treatment plan
Dates of patient outreach†
Date of recurrence
2. In treatment Date of dental evaluation
Date of treatment start
Date of treatment completion
Recommended and received dose and
treatment sessions
Treatment result (e.g., completed, not
Table 1 Data elements collected in chart review (Continued)
Phase/data type Data element
completed, delays)
Dates of treatment delays/complications
Type of treatment delays/complications
Dates post-treatment imaging ordered and
completed
Dates of patient outreach†
*P16 immunohistochemistry tests are recommended for newly diagnosed
oropharyngeal squamous cell carcinomas
†Supplemental data collected from health IT tool to describe implementation
of the tool, all other data collected from chart review
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Intervention effect estimates will be adjusted for potential
confounders including patient demographics, substance
use, housing status, and cancer stage.
Minimum detectable effects
In Cox models for time to event, the sample of 300 will
provide 80% power within two-sided tests with alpha of
0.05 to detect a hazard ratio of 2.25 for the effect of the
intervention, after adjusting for a linear temporal trend as
well as confounders. Estimation of preliminary effects
should be considered secondary objectives. The sample
size we propose is based on feasibility outcomes, and
therefore the simulations below demonstrate that the pilot
sample size would only detect a substantial effect size. De-
pending on the feasibility outcomes, we would proceed to
a larger trials with the ability to detect more modest ef-
fects. With the present number of patients, in Cox models
for time to event, the sample of 300 will provide 80%
power within two-sided tests with alpha of 0.05 to detect a
hazard ratio of 2.25 for the effect of the intervention, after
adjusting for a linear temporal trend as well as con-
founders. For binary outcomes including loss to follow-up
and completion of stages, it will provide 80% power to de-
tect intervention odds ratios of 3.4 to 6.7, depending on
the number of patients included in the analysis (200–300)
and the prevalence of the outcome (20 to 50%), again after
adjusting for a linear temporal trend and confounders.
These estimates were obtained using simulations imple-
mented in R Version 3.4.3.
Discussion
Health IT and management tools can improve the qual-
ity and safety of care delivered [17]. The tool designed in
this study has the potential to improve patient safety in
diagnostic, treatment, and monitoring steps for manage-
ment of patients with head and neck cancer. By mapping
out care processes in conjunction with frontline clini-
cians and incorporating this information with the sys-
tems engineering perspective provided by the SEIPS
framework, we developed a tool that clearly addresses
challenging aspects of providing care that both “keep cli-
nicians up at night” and contribute to poor clinical out-
comes. This study will evaluate the effectiveness of this
tool for improving timely delivery of care, and results
will inform the development of a multi-center trial to
evaluate effectiveness of this tool in a broader array of
healthcare settings.
Although our study is limited somewhat by the retro-
spective nature of our pre-intervention comparison, we
plan to address this limitation by adjusting for con-
founding by other temporal trends during the period of
comparison. The study is also unable to evaluate patient
progress towards diagnosis once referred to the
Otolaryngology-Head and Neck Surgery Clinic. Though
the tool will be used to monitor this aspect of care, there
is no reliable way to identify the pre-intervention com-
parison cohort.
Ultimately, we hope that this tool will be adapted to
other clinical contexts to expand the ability of clinics
and care providers to track and intervene on patients
not meeting treatment and monitoring goals. We plan
to publish study results in the scientific literature, as well
as compile and share results with the Otolaryngology-
Head and Neck Surgery Clinic included in this study.
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